Revolade
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Revolade, covering 2025-06-19 to 2026-02-26. Get the full timeline:
Most recent: EMA Authorised: Revolade (eltrombopag) — Novartis Europharm Limited